Phasefocus

Phasefocus is a UK-based startup revolutionizing live cell assays with its flagship product, Livecyte™ - a Kinetic Cytometer that captures high-contrast videos of live cells without the need for fluorescent labels or high-power illumination. This breakthrough technology allows monitoring and characterization of sensitive live cells, including stem cells and heterogeneous primary cancer cells, for extended periods in a 96-well plate format, thanks to its label-free approach. Founded in 2006, Phasefocus is powered by its patented Ptychographic computational imaging technology, enabling scientists to understand and compare the dynamic behavior of thousands of individual cells at an unprecedented depth. In June 2012, Phasefocus secured a $5.00M investment in a Venture Round, with funding coming from Ombu Group and Fusion IP, showcasing confidence from established investors. The company operates in the Biotechnology and Health Care industries, offering a range of products and services based on its disruptive Phasefocus Virtual Lens® technology. With a focus on label-free cell imaging and quantitative electron phase microscopy, Phasefocus is poised to bring new value to a wide range of analytical applications, including ophthalmic lens metrology.